Efficacy, Pharmacokinetics and Safety Comparison of Salmeterol Inhalation Powder Administered Via the HandiHaler® 2 and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE2CompletedINTERVENTIONAL

Enrollment

111

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

February 28, 2006

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Salmeterol xinafoate

DRUG

Serevent® Diskus®

DRUG

Placebo (HandiHaler®)

DRUG

Placebo (Diskus®)